LATEST NEWS

Treatment of hepatocellular carcinoma and liver metastases with hafnium oxide nanoparticles activated by SBRT: a phase I/II trial

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.